These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9728554)

  • 21. Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils.
    Baishanbo A; Gargala G; Delaunay A; François A; Ballet JJ; Favennec L
    Infect Immun; 2005 Aug; 73(8):5252-5. PubMed ID: 16041051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru.
    Xiao L; Bern C; Limor J; Sulaiman I; Roberts J; Checkley W; Cabrera L; Gilman RH; Lal AA
    J Infect Dis; 2001 Feb; 183(3):492-7. PubMed ID: 11133382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation.
    Lee SU; Joung M; Nam T; Park WY; Yu JR
    Korean J Parasitol; 2009 Mar; 47(1):7-11. PubMed ID: 19290085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-isolate variation of Cryptosporidium parvum small subunit ribosomal RNA genes from human hosts in England.
    Gibbons-Matthews C; Prescott AM
    Parasitol Res; 2003 Aug; 90(6):439-44. PubMed ID: 12764612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population genetic study of the Cryptosporidium parvum human genotype parasites.
    Sulaiman IM; Lal AA; Xiao L
    J Eukaryot Microbiol; 2001; Suppl():24S-27S. PubMed ID: 11906066
    [No Abstract]   [Full Text] [Related]  

  • 26. Presence of double-stranded RNAs in human and calf isolates of Cryptosporidium parvum.
    Khramtsov NV; Chung PA; Dykstra CC; Griffiths JK; Morgan UM; Arrowood MJ; Upton SJ
    J Parasitol; 2000 Apr; 86(2):275-82. PubMed ID: 10780545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.
    Hashim A; Clyne M; Mulcahy G; Akiyoshi D; Chalmers R; Bourke B
    Infect Immun; 2004 Oct; 72(10):6125-31. PubMed ID: 15385517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine Cryptosporidium parvum field isolates differ in cytopathogenicity in HCT-8 monolayers.
    Holzhausen I; Lendner M; Daugschies A
    Vet Parasitol; 2019 Sep; 273():67-70. PubMed ID: 31442896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of Cryptosporidium parvum isolates from human cryptosporidiosis cases in Scotland.
    Deshpande AP; Jones BL; Connelly L; Pollock KG; Brownlie S; Alexander CL
    Parasitology; 2015 Feb; 142(2):318-25. PubMed ID: 25244937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time nucleic acid sequence-based amplification (NASBA) assay targeting MIC1 for detection of Cryptosporidium parvum and Cryptosporidium hominis oocysts.
    Hønsvall BK; Robertson LJ
    Exp Parasitol; 2017 Jan; 172():61-67. PubMed ID: 27998735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Adeyemo O
    J Infect Dis; 1997 Jan; 175(1):218-21. PubMed ID: 8985225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectivity to experimental rodents of Cryptosporidium parvum oocysts from Siberian chipmunks (Tamias sibiricus) originated in the People's Republic of China.
    Matsui T; Fujino T; Kajima J; Tsuji M
    J Vet Med Sci; 2000 May; 62(5):487-9. PubMed ID: 10852396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotyping of Cryptosporidium parvum with microsatellite markers.
    Widmer G; Feng X; Tanriverdi S
    Methods Mol Biol; 2004; 268():177-87. PubMed ID: 15156029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence supporting zoonotic transmission of Cryptosporidium in rural New South Wales.
    Ng J; Eastwood K; Durrheim D; Massey P; Walker B; Armson A; Ryan U
    Exp Parasitol; 2008 May; 119(1):192-5. PubMed ID: 18343369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zoonotic cryptosporidiosis.
    Xiao L; Feng Y
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):309-23. PubMed ID: 18205803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross sectional study of prevalence, genetic diversity and zoonotic potential of Cryptosporidium parvum cycling in New Zealand dairy farms.
    Al Mawly J; Grinberg A; Velathanthiri N; French N
    Parasit Vectors; 2015 Apr; 8():240. PubMed ID: 25896433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The infectivity of Cryptosporidium parvum in healthy volunteers.
    DuPont HL; Chappell CL; Sterling CR; Okhuysen PC; Rose JB; Jakubowski W
    N Engl J Med; 1995 Mar; 332(13):855-9. PubMed ID: 7870140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal variability of Cryptosporidium in the Chesapeake Bay.
    Fayer R; Trout JM; Lewis EJ; Xiao L; Lal A; Jenkins MC; Graczyk TK
    Parasitol Res; 2002 Nov; 88(11):998-1003. PubMed ID: 12375166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic characterization of Cryptosporidium species from humans in Spain.
    Llorente MT; Clavel A; Goñi MP; Varea M; Seral C; Becerril R; Suarez L; Gómez-Lus R
    Parasitol Int; 2007 Sep; 56(3):201-5. PubMed ID: 17383227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.